Works by Colgan, Joseph P.


Results: 26
    1

    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 5, p. 448, doi. 10.1002/ajh.24671
    By:
    • Bennani, N. Nora;
    • LaPlant, Betsy R.;
    • Ansell, Stephen M.;
    • Habermann, Thomas. M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Markovic, Svetomir N.;
    • Nowakowski, Grzegorz S.;
    • Macon, William R.;
    • Reeder, Craig B.;
    • Mikhael, Joseph R.;
    • Northfelt, Donald W.;
    • Ghobrial, Irene M.;
    • Witzig, Thomas E.
    Publication type:
    Article
    2

    Elevated monoclonal and polyclonal serum immunoglobulin free light chain as prognostic factors in B- and T-cell non- Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2014, v. 89, n. 12, p. 1116, doi. 10.1002/ajh.23839
    By:
    • Witzig, Thomas E.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Link, Brian K.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Markovic, Svetomir N.;
    • Johnston, Patrick B.;
    • Lin, Yi;
    • Thompson, Carrie;
    • Gupta, Mamta;
    • Katzmann, Jerry A.;
    • Cerhan, James R.
    Publication type:
    Article
    3

    A phase I trial of immunostimulatory CpG 7909 oligodeoxynucleotide and <sup>90</sup>yttrium ibritumomab tiuxetan radioimmunotherapy for relapsed B-cell non-Hodgkin lymphoma.

    Published in:
    American Journal of Hematology, 2013, v. 88, n. 7, p. 589, doi. 10.1002/ajh.23460
    By:
    • Witzig, Thomas E.;
    • Wiseman, Gregory A.;
    • Maurer, Matthew J.;
    • Habermann, Thomas M.;
    • Micallef, Ivana N.M.;
    • Nowakowski, Grzegorz S.;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Porrata, Luis F.;
    • Link, Brian K.;
    • Zent, Clive S.;
    • Johnston, Patrick B.;
    • Shanafelt, Tait D.;
    • Allmer, Cristine;
    • Asmann, Yan W.;
    • Gupta, Mamta;
    • Ballas, Zuhair K.;
    • Smith, Brian J.;
    • Weiner, George J.
    Publication type:
    Article
    4
    5
    6
    7
    8

    Effectiveness of second line salvage chemotherapy with ifosfamide, carboplatin, and etoposide in patients with relapsed diffuse large B-cell lymphoma not responding to cis-platinum, cytosine arabinoside, and dexamethasone.

    Published in:
    Leukemia & Lymphoma, 2007, v. 48, n. 7, p. 1332, doi. 10.1080/10428190701435259
    By:
    • Simpson, Lijo;
    • Ansell, Stephen M.;
    • Colgan, Joseph P.;
    • Habermann, Thomas M.;
    • Inwards, David J.;
    • Ristow, Kay M.;
    • Johnston, Patrick B.;
    • Markovic, Svetomir N.;
    • Micallef, Ivana N.;
    • Porrata, Luis F.;
    • Witzig, Thomas E.
    Publication type:
    Article
    9
    10
    11

    Survival in patients with limited-stage peripheral T-cell lymphomas.

    Published in:
    Leukemia & Lymphoma, 2015, v. 56, n. 6, p. 1665, doi. 10.3109/10428194.2014.963078
    By:
    • Briski, Robert;
    • Feldman, Andrew L.;
    • Bailey, Nathaniel G.;
    • Lim, Megan S.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Inwards, David J.;
    • Colgan, Joseph P.;
    • Nowakowski, Grzegorz S.;
    • Kaminski, Mark S.;
    • Witzig, Thomas E.;
    • Ansell, Stephen M.;
    • Wilcox, Ryan A.
    Publication type:
    Article
    12

    Peripheral blood absolute lymphocyte/monocyte ratio during rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone treatment cycles predicts clinical outcomes in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2014, v. 55, n. 12, p. 2728, doi. 10.3109/10428194.2014.893313
    By:
    • Porrata, Luis F.;
    • Ristow, Kay M.;
    • Habermann, Thomas M.;
    • Witzig, Thomas E.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz;
    • Thompson, Carrie A.;
    • Markovic, Svetomir N.
    Publication type:
    Article
    13

    Absolute monocyte/lymphocyte count prognostic score is independent of immunohistochemically determined cell of origin in predicting survival in diffuse large B-cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2012, v. 53, n. 11, p. 2159, doi. 10.3109/10428194.2012.690605
    By:
    • Porrata, Luis F.;
    • Ristow, Kay;
    • Habermann, Thomas M.;
    • Ozsan, Nazan;
    • Dogan, Ahmet;
    • Macon, William;
    • Colgan, Joseph P.;
    • Witzig, Thomas E.;
    • Inwards, David J.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Nowakowski, Grzegorz S.;
    • Thompson, Carrie;
    • Markovic, Svetomir N.
    Publication type:
    Article
    14
    15
    16

    Absolute lymphocyte count predicts overall survival in follicular lymphomas.

    Published in:
    British Journal of Haematology, 2006, v. 134, n. 6, p. 596, doi. 10.1111/j.1365-2141.2006.06232.x
    By:
    • Siddiqui, Mustaqeem;
    • Ristow, Kay;
    • Markovic, Svetomir N.;
    • Witzig, Thomas E.;
    • Habermann, Thomas M.;
    • Colgan, Joseph P.;
    • Inwards, David J.;
    • White, William L.;
    • Ansell, Stephen M.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Call, Timothy G.;
    • Porrata, Luis F.
    Publication type:
    Article
    17
    18
    19
    20

    Testicular lymphoma is associated with a high incidence of extranodal recurrence.

    Published in:
    2000
    By:
    • Fonseca, Rafael;
    • Habermann, Thomas M.;
    • Colgan, Joseph P.;
    • O'Neill, Brian P.;
    • White, William L.;
    • Witzig, Thomas E.;
    • Egan, Kathleen S.;
    • Martenson, James A.;
    • Burgart, Lawrence J.;
    • Inwards, David J.;
    • Fonseca, R;
    • Habermann, T M;
    • Colgan, J P;
    • O'Neill, B P;
    • White, W L;
    • Witzig, T E;
    • Egan, K S;
    • Martenson, J A;
    • Burgart, L J;
    • Inwards, D J
    Publication type:
    journal article
    21

    Risk of histological transformation and therapy-related myelodysplasia/acute myeloid leukaemia in patients receiving radioimmunotherapy for follicular lymphoma.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 3, p. 427, doi. 10.1111/bjh.14688
    By:
    • Epperla, Narendranath;
    • Pham, Anthony Q.;
    • Burnette, Brian L.;
    • Wiseman, Gregory A.;
    • Habermann, Thomas M.;
    • Macon, William R.;
    • Ansell, Stephen M.;
    • Inwards, David J.;
    • Micallef, Ivana N.;
    • Johnston, Patrick B.;
    • Markovic, Svetomir N.;
    • Porrata, Luis F.;
    • Colgan, Joseph P.;
    • Ristow, Kay M.;
    • Nowakowski, Grzegorz S.;
    • Witzig, Thomas E.
    Publication type:
    Article
    22
    23
    24
    25
    26